SCHEMBL9708994

SCHEMBL9708994

O=C(O)CCCCCCCCCCCCCSc1ccccc1OCCCC(=O)O.O=C(O)CCCCCCCCCCCCSc1ccccc1OCCCC(=O)O.O=C(O)CCCCCCCCCCCSc1ccccc1OCCCC(=O)O

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 10/20 0.71
ALDH1A1 P00352 2/20 0.53
CYSLTR2 Q9NS75 4/20 0.46
CYSLTR1 Q9Y271 4/20 0.46
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46
LMNA P02545 1/20 0.45
PLA2G4B P0C869 1/20 0.44
LTB4R Q15722 1/20 0.43
LTB4R2 Q9NPC1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8158285 1.00 PTGS2 (0.71) PTGS2ALDH1A1CYSLTR2CYSLTR1HDAC3
SCHEMBL8158537 1.00 PTGS2 (0.71) PTGS2ALDH1A1CYSLTR2CYSLTR1HDAC3
SCHEMBL8163666 1.00 PTGS2 (0.71) PTGS2ALDH1A1CYSLTR2CYSLTR1HDAC3
SCHEMBL8164859 1.00 PTGS2 (0.71) PTGS2ALDH1A1CYSLTR2CYSLTR1HDAC3
SCHEMBL8163167 1.00 PTGS2 (0.71) PTGS2ALDH1A1CYSLTR2CYSLTR1HDAC3
SCHEMBL8158127 1.00 PTGS2 (0.71) PTGS2ALDH1A1CYSLTR2CYSLTR1HDAC3
SCHEMBL8159314 1.00 PTGS2 (0.71) PTGS2ALDH1A1CYSLTR2CYSLTR1HDAC3
SCHEMBL8157568 1.00 PTGS2 (0.71) PTGS2ALDH1A1CYSLTR2CYSLTR1HDAC3
SCHEMBL8150262 1.00 PTGS2 (0.71) PTGS2ALDH1A1CYSLTR2CYSLTR1HDAC3
SCHEMBL8156523 1.00 PTGS2 (0.71) PTGS2ALDH1A1CYSLTR2CYSLTR1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992016233-A1 PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF PROSTATIC CANCER CONTAINING A 5 ALPHA REDUCTASE INHIBITOR AND AN ANTIANDROGEN MERCK & CO., INC. (US) 1992-10-01 WO disclosed